| 摘要 |
Disclosed is a use of a compound in the manufacture of a medicament for treating cancer in a mammal for achieving in the mammal a plasma Cmax of about 10 ng/mL to about 30 ng/mL, comprising the compound (4-Methoxy-phenyl)-methyl-(2-methyl-quinazolin-4-yl)-amine hydrochloride, or a pharmaceutically acceptable salt or solvate thereof.
|
